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Although deficient CD8+ T cell responses have long
been associated with chronic viral infections, the
underlying mechanisms are still unclear. Here we
report that sustained transforming growth factor-
b (TGF-b) expression and phosphorylation of its
signalingmediator, Smad-2,weredistinctive features
of virus-specific CD8+ T cells during chronic versus
acute viral infections in vivo. The result was TGF-b-
dependent apoptosis of virus-specific CD8+ T cells
that related to upregulation of the proapoptotic
protein Bim during chronic infection. Moreover,
selective attenuation of TGF-b signaling in T cells
increased the numbers andmultiple functions of anti-
viral CD8+ T cells and enabled rapid eradication of the
persistence-prone virus and memory generation.
Finally, we found that cell-intrinsic TGF-b signaling
was responsible for virus-specific-CD8+ T cell ap-
optosis and decreased numbers but was not neces-
sary for their functional exhaustion. Our findings
reveal persistingTGF-b-Smadsignaling asahallmark
and key regulator of CD8+ T cell responses during
chronic viral infections in vivo.
INTRODUCTION
Microorganisms have evolved sophisticated mechanisms to
interfere with the ensuing immune response, leading to a race
between microbe (virulence) and immune system (resistance)
that dictates whether the pathogen establishes chronically or is
eliminated. Dramatic examples of human viruses wining this
race are human immunodeficiency virus (HIV), hepatitis B virus
(HBV), and hepatitis C virus (HCV), which currently infect more
than 500 million people worldwide (Letvin and Walker, 2003;
Rehermann and Nascimbeni, 2005). During several viral infec-
tions, progression into the chronic phase has been associated
with a varying degree of T cell dysfunction or ‘‘exhaustion,’’
ranging from diminished cytotoxicity to decreased production
of antiviral and growth cytokines and T cell deletion (Gruener
et al., 2001; Klenerman and Hill, 2005; Kostense et al., 2002;
Shankar et al., 2000; Wherry et al., 2003; Zajac et al., 1998).
Although these parameters of exhaustion have long been noted,the causative factors and the relative contributions of T cell-
intrinsic and T cell-extrinsic inhibitory signals in determining viral
persistence are not completely understood. Complete dissec-
tion of these pathways represents a major biomedical challenge
and has the potential to unveil novel therapeutic strategies to
treat persistently infected individuals. Recent studies with
lymphocytic choriomeningitis virus (LCMV) infection in mice
identified programmed cell death-1 (PD-1) and interleukin-10
(IL-10) as key inhibitory factors responsible for T cell suppression
and viral establishment during persistent infection (Barber et al.,
2006; Brooks et al., 2006; Ejrnaes et al., 2006). Although it is still
unclear whether these inhibitory signals act intrinsically on virus-
specific CD8+ T cells or indirectly through other cell types, these
reports indicate that viruses can exploit immune-regulatory
pathways to counteract the ensuing immune response. Impor-
tantly, these findings were rapidly extended to or independently
reported in humans (Boni et al., 2007; Clerici et al., 1994; Day
et al., 2006; Landay et al., 1996; Petrovas et al., 2006; Radzie-
wicz et al., 2007; Rigopoulou et al., 2005; Trautmann et al.,
2006; Urbani et al., 2006; Zhang et al., 2007), suggesting that
multiple conserved T cell-inhibitory pathways are shared be-
tween distinct chronic viral infections in different hosts.
TGF-b regulates cell proliferation, differentiation, survival, and
adhesion inmultiple cell types (Li et al., 2006b;Massague, 2008).
The critical function of TGF-b in suppressing autoreactive T cells
is evident in TGF-b1-deficient mice andmicewith complete abla-
tion of TGF-b signaling on T cells, which die from a multiorgan
autoimmune disease at 3–4 weeks of age (Kulkarni et al., 1993;
Li et al., 2006a; Marie et al., 2006; Shull et al., 1992). A milder
phenotype was observed in mice expressing a dominant-nega-
tive form of TGF-b receptor II from a modified CD4 promoter
(hereafter referred to as dnTGFBRII) that results in attenuation
of TGF-b signaling in CD4+ and CD8+ T cells (Gorelik and Flavell,
2000). The dnTGFBRII mice live without any detectable prob-
lems until 3–4 months of age when they began showing signs
of sickness, wasting, and diarrhea. This was associated with
multifocal inflammatory infiltrates and autoantibody secretion
(Gorelik and Flavell, 2000). As expected for such a pleiotropic
factor, the activities of TGF-b are subject to multiple layers of
regulation. This growth factor is normally secreted in a latent
configuration and is subsequently activated in the vicinity of
target cells to exert its function in a paracrine or autocrine
manner (Annes et al., 2003; Jenkins, 2008; Wipff and Hinz,
2008). TGF-b binding to its receptor induces phosphorylation
of Smad proteins, which mediate TGF-b signaling and areImmunity 31, 145–157, July 17, 2009 ª2009 Elsevier Inc. 145
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kinases, phosphatases, and ubiquitin ligases (Rubtsov and
Rudensky, 2007; Shi and Massague, 2003). As with many highly
tuned biological processes, alteration of TGF-b-Smad signaling
has been associated with tumorigenesis (Massague, 2008),
atherosclerosis (Topper, 2000), and autoimmunity (Li et al.,
2006b; Rubtsov and Rudensky, 2007), but its role in regulating
T cells responses and viral persistence during in vivo chronic
infection remained unknown. Here, we report that virus-specific
CD8+ T cells exhibited increased Smad-2 phosphorylation and
TGF-b expression during chronic compared to acute viral infec-
tion in vivo. Selective attenuation of TGF-b pathway in T cells
decreased the expression of the proapoptotic protein Bim and
increased survival and numbers of virus-specific CD8+ T cells.
Under these conditions, CD8+ T cells exhibited enhanced cyto-
toxicity, increased production of antiviral cytokines, and downre-
gulation of the inhibitory molecules PD-1 and IL-10. Notably,
although direct TGF-b signaling in virus-specific CD8+ T cells
was required for their increased apoptosis and reduced
numbers, it was not essential for their functional exhaustion
and PD-1 upregulation. The end result was rapid virus eradica-
tion and generation of an effective memory T cell response that
protected the host upon subsequent challenge.
RESULTS
Enhanced Smad-2 Phosphorylation and TGF-b
Expression in CD8+ T Cells during Chronic
LCMV Infection
To investigate the role of TGF-b in T cell suppression and viral
persistence, we infected mice with two genetically related
LCMV isolates that induce either acute or chronic viral infections,
but share identical T cell epitopes. The parental virus strain, Arm-
strong 53b (ARM), induces a strong CD8+ T cell response
responsible for acute viral clearance after 8–10 days postinfec-
tion (p.i.) (Ahmed et al., 1984). In contrast, LCMV clone 13 (Cl
13) initiates an abortive CD8+ T cell program that results in
a persistent infection for 60 to 90 days in blood and most tissues
(Ahmed et al., 1988; Moskophidis et al., 1993; Wherry et al.,
2003; Zajac et al., 1998). In particular, Cl 13 infection induces
CD8+ T cell deletion and exhaustion characterized by compro-
mised effector functions (Moskophidis et al., 1993; Ou et al.,
2001;Wherry et al., 2003; Zajac et al., 1998; and data not shown).
To examine downstream TGF-b signaling on virus-specific CD8+
T cells during acute versus chronic LCMV infection, the amounts
of phospho(p)-Smad-2 and 3 were analyzed on LCMV GP33-41
tetramer+ CD8+ T cells by FACS. A substantial increase in
p-Smad-2 and 3 was consistently observed in virus-specific
CD8+ T cells from Cl 13-infected compared to ARM-infected
mice (Figure 1A). To further evaluate Smad signaling on virus-
specific CD8+ T cells, we adoptively transferred naive CD45.2+
P14 TCR transgenic CD8+ T cells that are specific for the
GP33-41 LCMV epitope into CD45.1
+WTmice 1 day before infec-
tion with LCMV ARM or Cl 13. Consistent with the FACS data,
immunoblot analysis of P14 cells isolated at day 8–10 p.i.
showed enhanced Smad-2 phosphorylation during chronic
compared to acute LCMV infection (Figure 1B). Moreover,
a slight increase in Smad-2 phosphorylation was observed by
day 5 after Cl 13 infection. Minimal or no difference was146 Immunity 31, 145–157, July 17, 2009 ª2009 Elsevier Inc.observed in levels of total Smad-2 after ARM versus Cl 13 infec-
tion. Further studies addressing the source of this enhanced
Smad-2 signaling during chronic infection revealed an elevated
expression of TGF-b1 protein in virus-specific CD8
+ T cells
from Cl 13-infected mice compared to ARM-infected mice
(Figure 1C). In contrast, no differences were observed in the
expression of TGF-b receptor during either infection (Figure S1
available online). Together, these results indicated that TGF-b-
Smad signaling was turned on in antiviral CD8+ T cells during
both acute and chronic LCMV infection but became enhanced
and sustained only during persistent infection.
Attenuation of TGF-b Signaling in T Cells Enabled
Accumulation of Virus-Specific CD8+ T Cells
To investigate the biological significance of TGF-b signaling in
T cells during chronic viral infection, we infected dnTGFBRII
transgenic, which display selective attenuation of TGF-b
signaling in T cells (Gorelik and Flavell, 2000), with LCMV Cl
13. Numbers of peripheral blood CD8+ T cells specific for three
different MHC class I-restricted LCMV epitopes were monitored
by tetramer staining throughout the course of infection (Fig-
ure 1D). Cl 13-infected dnTGFBRII mice showed considerably
higher frequencies of GP33-41- and GP276-286-specific T cells
than WT controls. More impressively, the proportion of
NP396-404-specific CD8
+ T cells, which are largely deleted during
Cl 13 infection inWTmice (Ou et al., 2001), was also enhanced in
dnTGFBRII mice. The increased proportions of peripheral blood
tetramer-positive CD8+ T cells persisted for at least 45 days p.i.
Analysis of splenic T cells at day 9 p.i. also revealed elevated
frequencies and numbers of NP396-404-, GP33-41-, and GP276-286-
specific CD8+ T cells in dnTGFBRII mice to a similar extent as
WT-ARM-infected mice and up to 300 times higher than WT-Cl
13-infected mice (Figures 1E and 1F). Early kinetics indicated
that the initial expansion of CD8+ T cells was similar in WT and
dnTGFBRII Cl 13-infected mice (Figure 1G), suggesting that
the negative impact of TGF-b on the numbers of virus-specific
CD8+ T cells becomes effective at later time points after infec-
tion. Thus, reduced TGF-b receptor signaling in the dnTGFBRII
T cells increased the accumulation of virus-specific CD8+
T cells during chronic Cl 13 infection.
TGF-b Signaling Induced Apoptosis of Virus-Specific
CD8+ T Cells and Enhanced Bim Expression
Heightened accumulation of virus-specific CD8+ T cells in the Cl
13-infected dnTGFBRII mice could result from increased prolif-
eration and/or a reduction in cell death. To discriminate between
these possibilities, we first monitored proliferation in vivo by
analyzing BrdU incorporation on uninfected and Cl 13-infected
mice at days 7 and 9 p.i. Although increased proliferation of total
CD8+ T cells was observed before infection (Figure S2A), no
enhancement in the proliferation of GP33-41- and GP276-286-
specific T cells from dnTGFBRII versus WT mice was detected
after infection (Figure 2A and Figure S3A, respectively). We
then monitored apoptosis by Annexin V staining at the same
time points. Notably, in contrast to the higher percentages of
apoptotic CD8+ T cells detected in dnTGFBRII compared to
WT mice before infection (Figure S2B), a lower frequency of
Annexin V+ cells was determined within GP33-41- or GP276-286-
specific CD8+ T cells after Cl 13 infection (Figure 2B and
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Figure 1. TGF-b-Smad Signaling and Accumulation of Virus-Specific CD8+ T Cells during LCMV Infection
(A) WTmice were infected with LCMV ARMor Cl 13, and splenocytes were isolated at day 10 p.i. and stained with anti-CD8, Db-GP33-41 tetramers, and p-Smad-2
and 3 mAb. p-Smad-2 and 3 levels in Db-GP33-41 tetramer
+CD8+ T cells were determined by FACS. Bar graphs indicate the average mean fluorescence intensity
(MFI) ± standard deviation (SD) of 4 mice per group. Histograms depict one representative mouse per group. Thin line, isotype control.
(B andC) Donor CD45.2+ P14 TCR transgenic CD8+ T cells were transferred intoWTCD45.1+ recipients, hostswere infectedwith LCMVARMor Cl 13, and pooled
P14 cells were FACS purified at day 5 or 8–10 p.i. and processed for immunoblot blot. Phospholipase-g (PLC-g) was used as loading control.
(B) Amounts of p-Smad-2 and total Smad-2 in P14 cells.
(C) TGF-b1 expression in P14 cells.
(D–G) WT (black circles or bars) or dnTGFBRII (white squares or bars) mice were infected with LCMV Cl 13. WT-ARM infected mice were processed as controls
(striped bars). Virus-specific CD8+ T cells from blood (D) or spleen (E–G) were stained with H2Db-NP396-404, D
b-GP33-41, and/or D
b-GP276-286 tetramers.
(D) Log-scaled plots showing average frequencies ± SD of tetramer+CD8+ blood cells at the indicated times p.i.
(E) Dot plots displaying tetramer staining profiles in splenocytes from a representative mouse per group at day 9 p.i. Numbers indicate percent tetramer+CD8+
cells in the respective gate.
(F and G) Total numbers of tetramer+CD8+ cells per spleen at day 9 (F) or days 1 through 9 (G) p.i. Note that numbers of tetramer+ T cells were similar to back-
ground levels at day 1 and 3 p.i.
All results are representative of two or three independent experiments with three to five mice per group each.
LCMV ARM versus Cl 13 or WT versus dnTGFBRII as indicated; *p < 0.05, **p < 0.005, and ***p < 0.0005.Figure S3B, respectively). Thus, dnTGFBRII mice showed in-
creased CD8+ T cell proliferation and death before infection
but similar proliferation and enhanced survival of virus-specific
CD8+ T cells during chronic LCMV infection.
The BH3-only protein Bim has been implicated in the killing of
virus-specific CD8+ T cells during chronic infection with LCMVCl
13 andmurine g-herpesvirus (Grayson et al., 2006; Hughes et al.,
2008). Accordingly, we observed that the three isoforms of Bim
(i.e., BIM-EL, L, and S) were markedly upregulated after Cl 13
versus ARM LCMV infection (Figure 2C and data not shown).Notably, upregulation of Bim coincided with enhanced Smad-2
phosphorylation in virus-specific CD8+ T cells (Figure 1B), sug-
gesting that TGF-b signaling could induce Bim upregulation.
To test this possibility, we analyzed Bim expression in LCMV-
specific CD8+ T cells isolated from WT or dnTGFBRII Cl 13-in-
fected mice. We found that the expression of both Bim-EL and
Bim-L isoforms were dramatically decreased in dnTGFBRII
virus-specific CD8+ T cells compared to those from WT controls
(Figure 2D). Altogether, these data indicate that TGF-b signaling
promoted apoptosis of virus-specific CD8+ T cells and wasImmunity 31, 145–157, July 17, 2009 ª2009 Elsevier Inc. 147
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in vivo.
Attenuation of TGF-b Signaling in T Cells Prevented
CD8+ T Cell Dysfunction during Cl 13 Infection
In the next series of experiments, we investigated whether dimin-
ished TGF-b receptor signaling in T cells enabled the acquisition
of effector CD8+T cell functions. Production of IFN-g, TNF-a, and
IL-2 was determined in CD8+ T cells from uninfected and day 9Cl
13-infected WT or dnTGFBRII mice by ex vivo stimulation. We
observed that uninfected dnTGFBRII mice exhibited about
2-fold increase in the percentage of IFN-g+ cells but no increased
frequencies of IL-2- and TNF-a-producing cells after PMA-iono-
micyn stimulation (Figures S2C and S2D). As previously reported
during Cl 13 infection (Wherry et al., 2003; Zajac et al., 1998),
a large proportion of virus-specific CD8+ T cells from WT mice
were unable to produce antiviral cytokines (Figure 3A). In stark
contrast, CD8+ T cells from dnTGFBRII mice display functional
effector activity to similar extent as WT-ARM-infected mice, as
indicated by the dramatically elevated frequencies of epitope-
specific CD8+ T cells that produce IFN-g, TNF-a, and/or IL-2
upon restimulation with NP396-404, GP33-41, or GP276-286 LCMV
peptides (Figure 3A; Figure S4). Moreover, substantial numbers
of multiproducer CD8+ T cells, which simultaneously secrete
two or three of the cytokines studied, were detected in
dnTGFBRII mice (Figure S5). Cytotoxic activity toward target
cells loaded with either NP396-404 or GP33-41 peptides was mark-
edly enhanced in CD8+ T cells from Cl 13-infected dnTGFBRII
A B
C D
Figure 2. dnTGFBRII Mice Show Increased
Survival and Reduced Bim Expression in
Virus-Specific CD8+ T Cells
(A and B) WT (black bars) or dnTGFBRII (white
bars) mice were infected with LCMV Cl 13. Spleen
cells were isolated at day 7 and 9 p.i., and BrdU
incorporation (A) and Annexin V staining (B) of
H2Db GP33-41 tetramer
+CD8+ T cells were deter-
mined. Histograms display a representative
mouse per group and numbers indicate the
frequency of cells within regions.
(C and D) Virus-specific CD8+ T cells were FACS
isolated from WT mice infected with LCMV ARM
or Cl 13 (C) or dnTGFBRII mice infected with Cl
13 (D) at days 8–10 p.i. Cells were processed by
immunoblot and the amounts of Bim EL and Bim
L isoforms are shown.
Phospholipase-g (PLC-g) was used as loading
control. Results are representative of 2–3 indepen-
dent experiments with 3–5 mice per group. WT
versus dnTGFBRII; *p < 0.05 and **p < 0.005.
versus WT mice at day 9 p.i. (Figure 3B).
Consistently, a larger number of virus-
specific CD8+ T cells from dnTGFBRII
mice exhibited surface expression of the
lysosomal markers CD107a-b upon
GP33-41 peptide restimulation, indicating
their increased cell degranulation com-
pared to WT controls (Figure 3C). Finally,
we observed that the previously de-
scribed inhibitory molecules PD-1 in
virus-specific CD8+ T cells (Barber et al., 2006; Boni et al.,
2007; Day et al., 2006; Petrovas et al., 2006; Radziewicz et al.,
2007; Trautmann et al., 2006; Urbani et al., 2006; Zhang et al.,
2007) and IL-10 in splenocytes (Brooks et al., 2006; Ejrnaes
et al., 2006) were reduced in dnTGFBRII mice compared to WT
controls at day 9 and later after Cl 13 infection (Figures 3D and
3E; Figure S6) but were similar at day 5 p.i. or slightly increased
in uninfected dnTGFBRII mice (Figures 3D and 3E; Figure S2E).
These results indicated that attenuation of TGF-b signaling
prevented both CD8+ T cell functional exhaustion and sustained
upregulation of PD-1 and IL-10. Notably, the similar expression
of PD-1 and IL-10 early after infection of dnTGFBRII mice sug-
gested that their latter reduction was not a consequence of
direct TGF-b modulation.
Reduced TGF-b Signaling in T Cells Accelerated
Cl 13 Clearance
We next assessed whether the enhanced CD8+ T cell responses
observed in dnTGFBRII mice during Cl 13 infection were suffi-
cient to eradicate the virus. For this purpose, we determined
virus titers in the blood of WT or dnTGFBRII mice at days 8,
15, 45, and 49 after Cl 13 infection. In contrast to the sustained
high titers in WT controls, dnTGFBRII mice had less LCMV in
their blood at day 8 p.i., and their viremia cleared by day 15 p.i.
without recurrence within the 50-day period investigated
(Figure 4A). At day 15 p.i., liver and brain tissues from WT mice
exhibited substantial virus titers of107 PFU/g. In stark contrast,
dnTGFBRII mice had completely purgedCl 13 from these tissues148 Immunity 31, 145–157, July 17, 2009 ª2009 Elsevier Inc.
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Figure 3. Functional Virus-Specific CD8+ T Cells in LCMV Cl 13-Infected dnTGFBRII Mice
WT (black bars or histograms) or dnTGFBRII (white bars or histograms) mice were infected with LCMV Cl 13 and splenocytes obtained at day 9 p.i. unless other-
wise stated.
(A) Cells were stimulated with NP396-404, GP33-41, and GP276-286 LCMV peptides and production of IFN-g, TNF-a, and IL-2 by CD8
+ T cells was analyzed. Bar
graphs depict the average percent ± SD of cytokine-producing CD8+ T cells normalized to the number of tetramer+ cells in the same spleen. Dot plots display
a representative mouse for each peptide. Numbers indicate the percent of cells within the indicted gates.
(B) The cytotoxic capacity of virus-specific CD8+ T cells was quantified by 51Cr release assay against targets cells loaded with LCMV peptides at the indicated
ratios. The graphs show average percent of specific lysis ± SD.
(C) Cells were stimulated with GP33-41 peptide in the presence of FITC-labeled-anti-CD107a-b. Dot plots represent one representative mouse per group.
(D) PD-1 expression was quantified in Db-GP33-41
+CD8+ and Db-GP276-286
+CD8+ splenocytes. Bar graphs indicate the average PD-1 MFI ± SD. The histograms
show representative data from one mouse per group. Shown are PD-1 expression on total CD8+ cells from uninfected controls (thin line) or on the indicated
tetramer-positive dnTGFbRII (thick line) or WT (filled histogram) CD8+ T cells from Cl 13-infected mice.
(E) IL-10 mRNA expression was quantified by real-time RT-PCR and are shown as average ± SD normalized to GAPDH mRNA.
WT-ARM-infected mice at day 9 p.i. were processed as controls (striped bars).
Results are representative of two or three independent experiments with three to four mice each.
WT versus dnTGFBRII; *p < 0.05 and **p < 0.005.and had mostly cleared the virus from their lungs (Figure 4B).
Importantly, kinetics of early infection in spleen indicated that
viral growth at days 1, 3, and 5 p.i. was indistinguishable in WT
versus dnTGFBRII mice and became reduced or undetectable
only by days 9 and 15 p.i., respectively (Figures 4C and 4D).
Interestingly, the LCMV titers in dnTGFBRII mice at day 8 p.i.
showed a strong negative correlation with the frequency of
CD8+ T cells producing IFN-g and TNF-a upon ex vivo GP33-41
stimulation (Figure S7). Moreover, depletion of CD8+ T cells in
dnTGFBRII mice prevented virus containment (Figure 4E), pro-viding a causal link between improved CD8+ T cell responses
and Cl 13 eradication in dnTGFBRII mice.
Given that dnTGFBRII mice exhibit signs of autoimmunity
(Gorelik and Flavell, 2000), we evaluated whether TGF-b attenu-
ation of T cells could increase or accelerate tissue damage
during viral infection. To this end, we first compared histological
sections of liver, lung, and stomach from 2-month-old WT and
dnTGFBRII mice at day 10 p.i. (Figure S8). Cl 13 infection
increased mononuclear cell infiltration in all these organs of WT
as well as those of dnTGFBRII mice compared to uninfectedImmunity 31, 145–157, July 17, 2009 ª2009 Elsevier Inc. 149
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Figure 4. dnTGFBRII Mice Exhibit Accelerated Clearance of Persistent LCMV
WT (black circles or bars) or dnTGFBRII (white squares or bars) mice were infected with LCMV Cl 13.
(A–C) Virus titers were determined by plaque assay in blood (A) and spleen (C) at the indicated time points and average LCMV titers ± SD are shown.
(B) The average viral titers in liver, brain, and lung at day 15 p.i. are indicated by the lines and individual mice represented by each symbol.
(D) Spleen sections from WT or dnTGFBRII at day 3 or 15 p.i. were stained with anti-LCMV Ab. Panoramic spleen images are 103 magnification.
(E) dnTGFBRII mice were injected with depleting anti-CD8 (white triangles) and virus titers in blood determined at day 12 p.i.
(F) Plasma amounts of the indicated molecules were determined at day 10 p.i. Bar graphs show mean values ± SD. Results are representative of two or three
independent experiments with three or five mice per group.
WT versus dnTGFBRII or as indicated; *p < 0.05.controls. Consistent with their more potent T cell response, the
cell infiltrate was larger in dnTGFBRII than in WT infected mice.
However, no enhancement in tissue damage was observed in
liver, lung, or stomach of infected dnTGFBRII mice compared
to WT controls. In fact, fewer vacuolated hepatocytes were
observed in Cl 13-infected dnTGFBRII versus WT mice, likely
because of the reduced viral burden described above. More-
over, in agreement with the 100% survival of Cl 13-infected
dnTGFBRII mice until at least 66 days p.i. (data not shown),
amounts of plasma aspartate aminotransferase (AST), alanine
aminotransferase (ALT), alkaline phosphatase (AP), glucose,
and blood urea nitrogen (BUN) were comparable in dnTGFBRII
and WT mice at day 10 p.i. (Figure 4F). Creatinine was undetect-
able in all mice tested (data not shown).
These findings demonstrated that attenuation of TGF-b
signaling in T cells allowed for a strong CD8+ T cell response in150 Immunity 31, 145–157, July 17, 2009 ª2009 Elsevier Inc.Cl 13-infected mice that prevented persistent infection without
apparent enhancement of immunopathology.
Effective Memory CD8+ T Cell Response
in Cl 13-Infected dnTGFBRII Mice
The fact that LCMV-specific CD8+ T cells were detected in
dnTGFBRII mice long after viral elimination (Figure 1D, day 45 p.i.)
suggested that early control of Cl 13 infection enabled the
successful generation of T cell memory under conditions of
constrained TGF-b signaling. To further explore this possibility,
we evaluated the functional properties of these long-lasting
virus-specific CD8+ T cells by restimulation with NP396-404,
GP33-41, orGP276-286 LCMVpeptides at day 49afterCl 13 infection
(Figure 5A). Frequencies of IFN-g- and/or TNF-a-producing CD8+
T cells were substantially elevated in dnTGFBRII compared toWT
mice. Moreover, at 2 months p.i., GP33-41- and GP276-286-specific
Immunity
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Figure 5. Memory CD8+ T Cell Response in Cl 13-Infected dnTGFBRII Mice
WT (black bars or histograms) or dnTGFBRII (white bars or gray histograms) mice were infected with LCMV Cl 13.
(A) Splenocytes were obtained at day 49 p.i. and stimulated with NP396-404, GP33-41, and/or GP276-286 LCMV peptides, and production of IFN-g and TNF-a by
CD8+ T cells was analyzed. Bar graphs depict average percent ± SD of cytokine-producing CD8+ T cells normalized to the number of corresponding
tetramer+ cells in the same spleen. Dot plots display one representative mouse per group; numbers indicate the percent of cells within the respective gate.
(B) CD127 expression was quantified in Db-GP33-41
+CD8+ and Db-GP276-286
+CD8+ blood cells after 2 months p.i. Bar graphs indicate the average CD127
MFI ± SD. ARM-infected mice were processed as controls (striped bars). Histograms depict one representative mouse per group.
(C) dnTGFBRII mice were rechallenged with LCMV Cl 13 (secondary, 2) and processed in parallel to primary-infected dnTGFBRII mice (1). Average viral
titers in blood and liver at day 5 p.i. ± SD are depicted.
Results are representative of two experiments with three to five mice per group.
WT versus dnTGFBRII or 1 versus 2; *p < 0.05, **p < 0.005, and ***p < 0.0005.T cells from dnTGFBRII Cl 13-infected mice exhibited a more
differentiated memory phenotype, comparable to the one
observed inWT-ARM-infected mice, as indicated by upregulation
of CD127, Ly6C, and CD122 (Figure 5B; Figure S9). Finally, in
contrast to primary infection, Cl 13 rechallenge in dnTGFBRII
mice resulted in complete viral clearance from blood and
dramatic virus reduction in the liver already by day 5 p.i.
(Figure 5C), similar to the phenotype observed upon Cl 13 rechal-
lenge of ARM-immune mice (data not shown). Thus, attenuated
TGF-b receptor signaling in T cells was compatible with the
generation of a functional and effective memory CD8+ T cell
response.Cell-Intrinsic TGF-b Signaling Was Required for CD8
TCellDeletionbutDispensableforFunctionalExhaustion
To discriminate between direct (cell-intrinsic) versus indirect
TGF-b effects on virus-specific CD8+ T cells, we first coinjected
WT (CD45.1+CD45.2+) or dnTGFBRII (CD45.2+) P14-TCR tg
CD8+ T cells into CD45.1+ WT recipients, infected these mice
with Cl 13 1 day after cell transfer, and evaluated BrdU in-
corporation and Annexin V staining (Figures 6A and 6B, respec-
tively). Again, we detected similar extents of proliferation, but
lower Annexin V binding in P14-dnTGFBRII versus P14-WT
CD8+ T cells. These data were validated in WT-dnTGFBRII
bone marrow (BM) mixed chimeras showing similar BrdUImmunity 31, 145–157, July 17, 2009 ª2009 Elsevier Inc. 151
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Figure 6. Direct and Indirect TGF-b Effects on Virus-Specific CD8+ T Cells
(A and B) P14-WT (black bars) and P14-dnTGFBRII (white bars) CD8+ T cells were cotransfered into WT mice 1 day before LCMV Cl 13 infection. BrdU incor-
poration (A) and Annexin V staining (B) of P14 cells were determined at day 8 p.i. Bar graphs depict the average frequency of positive cells ± SD. Histograms
display a representative mouse and numbers indicate the frequency of cells within regions.
(C–F)WT-dnTGFBRII mixedBMchimeraswere processed to analyze CD45.1+WT andCD45.2+ dnTGFBRII CD8+ T cells before (preinfection) and at day 8 after Cl
13 infection.
(C) Total CD8+ T cells in blood before infection and within spleen Db-NP 396-404 and D
b-GP33-41 tetramer
+ cells at day 8 p.i.
(D) Total numbers of tetramer+CD8+ cells per spleen at day 8 p.i.
(E) Production of IFN-g and TNF-a after GP33-41 and GP276-286 LCMV peptide stimulation at day 8 p.i.
(F) PD-1 expression within Db-GP33-41 tetramer
+ cells at day 8 p.i. Dot plots display a representative mouse and numbers indicate the frequency of cells within
regions.
Results are representative of two independent experiments with 4–8 mice per group. *p < 0.05, **p < 0.0005.incorporation and reduced Annexin V staining in dnTGFBRII
compared to WT DbGP33-41- and D
bGP276-286-specific CD8
+
T cells (data not shown). Moreover, the ratio of dnTGFBRII-
WT CD8+ T cells in the BM chimeras was %1 before infection
and dramatically increased up to 16 times within DbNP396-404-,
DbGP33-41-, or D
bGP276-286-specific CD8
+ T cell populations at
day 8 after Cl 13 infection (Figure 6C). Importantly, although unin-
fected dnTGFBRII mice and most of the BM chimeras showed
enhanced expression of some activation markers in dnTGFBRII
CD8+ T cells compared toWT counterparts (Figure S2F and data
not shown), a minority of BM chimeras exhibited similar ex-
pression of activation markers in WT and dnTGFBRII CD8+
T cells before the infection (Figure S10A). Even in the latter-
mentioned scenario, we observed a significant increase in
dnTGFBRII-WT ratio in virus-specific CD8+ T cells at day 8 p.i.
compared to uninfected total CD8+ T cell (Figures S10B and
S10C). These data clearly dissociate the disparate activation of
WT and dnTGFBRII total CD8+ T cells before infection and the152 Immunity 31, 145–157, July 17, 2009 ª2009 Elsevier Inc.increased numbers of virus-specific CD8+ T cells in
dnTGFBRII-Cl13-infected mice at day 8 p.i. Notably, the total
numbers of virus-specific CD8+ T cells recovered from BM
mixed chimeras were 10 times lower than the ones recovered
in nonirradiated dnTGFBRII mice after Cl 13 infection (Figure 6D
versus Figure 1F) and apparently insufficient to control viremia
by day 9 p.i. (7.2 3 105 ± 2.0 3 105 PFU/ml; n = 8 mice), which
was as high as in WT mice (Figure 4C). Similarly, lower numbers
of splenocytes and delayed viral clearance were observed in
previous experiments with WT-WT BM chimeras compared to
nonirradiated WT mice during Cl 13 infection (unpublished
results), suggesting an immunocompromised response of BM
chimeras during Cl 13 infection. Interestingly, under the afore-
mentioned conditions, WT and dnTGFBRII virus-specific CD8+
T cells from BM mixed chimeras showed comparable functional
exhaustion as judged by their ability to produce IFN-g and TNF-a
upon GP33-41 or GP276-286 peptide stimulation (Figure 6E). In
addition, PD-1 expression was also comparable in WT and
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+ T from the mixed chimeras
(Figure 6F).
Together these data demonstrated that direct TGF-b signaling
was necessary for virus-specific CD8+ T cell apoptosis and
decreased numbers but dispensable for CD8+ T cell dysfunction
and PD-1 upregulation during Cl 13 infection.
Functional CD4+ T Cell Response in dnTGFBRII Mice
Infected with Cl 13
In the following series of experiments, we investigated the CD4+
T cell response in dnTGFBRII andWTmice during Cl 13 infection.
Assessing the numbers and frequencies of CD4+ T cells specific
for the IAb-GP66-77 LCMV epitope at day 9 p.i. revealed a 2.5-fold
elevation in the numbers and a modest increase in the frequency
of LCMV-specific-CD4+ T cells in dnTGFBRII compared toWTCl
13-infectedmice (Figures 7A and 7B, respectively). Furthermore,
a greater number and fraction of virus-specific CD4+ T cells from
dnTGFBRII mice produced IFN-g, TNF-a, and IL-2 when re-
stimulated with the LCMV GP66-77 peptide compared to WT
controls (Figures 7A, 7C, and 7D). Determination of viremia in
CD4-depleted dnTGFBRII mice showed partial or complete viral
containment (Figure 7E), indicating that the persistent-prone
virus was still repressed in the absence of CD4+ T cells.
These data indicated that diminished TGF-b signaling in T cells




B Figure 7. dnTGFBRII Mice Mount a Potent
Antiviral CD4+ T Cell Response
WT (black bars or black circles) or dnTGFBRII
(white bars or white squares) mice were infected
with LCMV Cl 13 and splenocytes obtained at
day 9 p.i.
(A–D) Virus-specific CD4+ T cells were stained with
IAb-GP66-77 tetramers or stimulated with GP66-77
LCMV peptide to analyze the production of IFN-g,
TNF-a, and IL-2.
(A) Average number ± SD of total IAb-GP66-77
+ or
cytokine-producing CD4+ cells per spleen.
(B and C) Dot plots represent one representative
mouse per group; numbers denote the percent
cells within each gate.
(D) Mean percentages ± SD of cytokine-produc-
ing CD4+ T cells normalized to the number of
IAb-GP66-77 tetramer
+ cells in the same spleen.
(E) dnTGFBRII mice were injected with depleting
anti-CD4 (white triangles) and virus titers in blood
determined at day 12 p.i. Data are representative
of two or three independent experiments with three
to four mice each.
WT versus dnTGFBRII, or dnTGFBRII-anti-CD4;
*p < 0.05, **p < 0.005 and ***p < 0.0005.
CD4+ T cell response that contributed to
but was not essential for viral control.
DISCUSSION
Viral persistence in humans and mice has
been previously associated with insuffi-
cient numbers and/or function of CD8+
T cells (Klenerman and Hill, 2005; Shin
and Wherry, 2007). Our study reported here demonstrates that
sustained TGF-b-Smad signaling was a key molecular feature
that directly compromised the magnitude of CD8+ T cell
responses during chronic viral infection in vivo. Remarkably, by
itself, the attenuation of TGF-b signaling on T cells enabled rapid
viral eradication instead of persistence. Considering that
numerous other features of chronic infections are shared
between mice and humans (Klenerman and Hill, 2005; Shin
and Wherry, 2007), it is likely that the effect of TGF-b on T cells
represents a common pathway leading to CD8+ T cell suppres-
sion in different hosts. Indeed, previous reports indicate that
TGF-b blockade in vitro restores the response of T cells from
HCV- or HIV-infected humans or from simian immunodeficiency
virus (SIV)-infected macaques (Alatrakchi et al., 2007; Cumont
et al., 2007; Garba et al., 2002).
Consistent with previous studies demonstrating TGF-
b production after acute LCMV infection (Su et al., 1991, 1993),
we found that TGF-b-Smad signaling was initiated early in
virus-specific CD8+ T cells after both acute and chronic viral
infections. However, although CD8+ T cell Smad-2 phosphoryla-
tion decreased during ARM infection, it was conversely
enhanced and sustained during Cl 13 infection. The amounts
of active Smad-2 correlated with enhanced TGF-b1 protein
expression in virus-specific CD8+ T cells, suggesting an auto-
crine feedback loop that perpetuates TGF-b-Smad signalingImmunity 31, 145–157, July 17, 2009 ª2009 Elsevier Inc. 153
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ces of TGF-b are critical for silencing autoreactive T cells in unin-
fected mice (Longenecker et al., 2002; McGeachy and Cua,
2007). A previous study indicates that TGF-b RNA and biological
activity are induced upon T cell activation (Kehrl et al., 1986).
Thus, it is likely that TGF-b expression is induced by TCR stimu-
lation of virus-specific CD8+ T cells during infection. In this line,
the enhanced and persisting TGF-b expression during Cl13
infection could result from high and continuous antigenic stimu-
lation of virus-specific CD8+ T cells. Alternatively, TGF-b can be-
produced by a variety of cell types (Rubtsov and Rudensky,
2007), and therefore other cell sources could contribute to the
enhanced and persisting Smad signaling during chronic infec-
tion.
A recent in vivo study documented that a low CD8+ T cell
effector/target ratio after SIV or LCMV infection correlates with
poor viral control and persistence (Li et al., 2009). We demon-
strated that enhanced TGF-b-Smad signaling induced ap-
optosis in a cell-intrinsic fashion and reduced the number of
effector CD8+ T cells available to fight the infection. Notably,
there was a substantial preservation of NP396-404-specific CD8
T cell response, which is dominant during acute LCMV infection
and mostly eliminated during chronic infection (Ou et al., 2001)
and might be especially protective. Moreover, we found that
attenuation of TGF-b signaling on T cells reduced the expression
of the proapoptotic protein Bim in virus-specific CD8+ T cell
during chronic infection. Previous studies have demonstrated
that Bim is involved in limiting antiviral CD8+ T cell responses
during Cl 13 infection (Grayson et al., 2006), indicating that up-
regulation of Bim is at least in part responsible for TGF-b-
induced deletion of virus-specific CD8+ T cells. However,
some LCMV-specific CD8+ T cells are more effectively rescued
in dnTGFBRII mice than in Bim-deficient mice during Cl 13 infec-
tion (Grayson et al., 2006). Therefore, other TGF-b-induced
apoptotic mechanisms may be in place or become active in
the absence of Bim. Interestingly, the proliferation of virus-
specific CD8+ T cells was not enhanced in dnTGFBRII-Cl 13-in-
fected mice. This finding contrasts with the inhibitory effect of
TGF-b on the proliferation of CD8+ T cells before infection (Fig-
ure S2A; Li et al., 2006b). The differential outcome of TGF-
b signaling before and after infection could reflect variations in
cell cycle stages at the time when TGF-b signaling becomes
effective as has been previously described in epithelial cells
(Massague, 2008).
Besides noting a reduction in the extent of cell death, we found
that the attenuation of TGF-b signaling globally improved the
functions of virus-specific T cells during chronic LCMV infection.
In particular, the generation of multi-cytokine-producing CD8+
T cells has important implications, because they have been
associated with better control of several human infections (Betts
et al., 2006; Kannanganat et al., 2007; Seder et al., 2008). Impor-
tantly, the data obtained from WT-dnTGFBRII mixed chimeras
indicated that TGF-b suppression of CD8+ T cell function is
mediated through indirect mechanisms during Cl 13 infection.
Two recent reports demonstrated that high and persisting
antigen levels cause CD8+ T cell exhaustion (Bucks et al.,
2009; Mueller and Ahmed, 2009). Therefore, it is likely that the
increased function of CD8+ T cells in dnTGFBRII-infected mice
mostly resulted from the reduced viremia attained by the154 Immunity 31, 145–157, July 17, 2009 ª2009 Elsevier Inc.sufficiently elevated numbers of virus-specific CD8+ T cells. In
addition, TGF-b-dependent CD8+ T cell-extrinsic regulatory
elements, which are absent in dnTGFBRII mice but compen-
sated by WT cells in mixed chimeras, may also contribute to
the enhanced CD8+ T cell function in dnTGFBRII mice. Given
that interference with TGF-b signaling results in decreased
numbers of regulatory T (Treg) cells (data not shown; Li et al.,
2006a; Marie et al., 2006), the improved antiviral T cell responses
in dnTGFBRII mice could result partly from reduced Treg cell
activity.
Suppression of CD8+ T cells seems to result from multiple
nonoverlapping regulatory circuits during chronic viral infection
(Blackburn et al., 2009; Brooks et al., 2008; Wherry et al., 2007).
It is intriguing that the functional differentiation of virus-specific
T cells in dnTGFBRII mice coincided with downregulation of
previously characterized inhibitory molecules such as PD-1
and IL-10 at day 9 p.i. (Barber et al., 2006; Brooks et al.,
2006; Ejrnaes et al., 2006). However, this is likely secondary
to the decreased viral titers observed in dnTGFBRII mice
because under conditions of similar viral load (day 5 p.i.),
attenuation of TGF-b signaling in T cells did not affect the
expression of IL-10 or PD-1. Consistently, WT and dnTGFBRII
virus-specific CD8+ T cells exposed to the same infectious
environment in mixed chimeras showed comparable PD-1 ex-
pression.
The transient but detectable expression of TGF-b and
p-Smad-2, as well as other inhibitory molecules (Barber et al.,
2006; Blackburn et al., 2009; Brooks et al., 2006; Wherry et al.,
2007), early during ARM and Cl 13 infection suggest that nega-
tive and positive T cell signals coexist during both acute and
chronic viral infections. It is interesting that, even when TGF-b-
Smad signaling was clearly detected at day 5 after Cl 13 infec-
tion, the numbers of virus-specific CD8+ T cells were similar in
WT and dnTGFBRII mice. This observation suggests that there
is an initial window of time when TGF-b signaling is ongoing
but its negative effect on the magnitude of CD8+ T cell response
is overcome or modulated by the contextual signaling. It is
tempting to hypothesize that if the virus (e.g., ARM) is at least
partially controlled by the ensuing immune response during
such an initial window of time, CD8+ T cells would benefit from
less antigenic stimulation and poor induction of TGF-b during
the later phase of the response, when the negative effect of
TGF-b is no longer restrained. On the other hand, during infection
with a persistence-prone virus, such as Cl 13, which infects
a large number of antigen-presenting and fribroreticular cells
(Li et al., 2009; Matloubian et al., 1993; Mueller et al., 2007; Sev-
illa et al., 2003), the virus cannot be rapidly repressed providing
continuous antigenic stimulation and TGF-b induction in the later
phase of the infection, when the negative role of TGF-b is effec-
tive. Under the later conditions, the brake imposed by TGF-b on
T cells represents a determinant factor for viral persistence.
Interestingly, we recently reported inhibition of type I IFN
produced by plasmacytoid dendritic cells during in vivo LCMV
infection, suggesting that regulatory pathways may impose
a brake on the innate immune system as well (Zuniga et al.,
2008). It is important to note that immunoregulatory signals
may have evolved to high tune themagnitude of the ensuing anti-
viral response to prevent excessive tissue damage. However,
the fact that attenuation of certain regulatory circuits during
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drastic immunopathology (Barber et al., 2006; Blackburn et al.,
2009; Brooks et al., 2006, 2008; Ejrnaes et al., 2006; Velu
et al., 2009) implies that there may be a window of therapeutic
opportunity to boost antiviral immunity during chronic infections.
The potent T cell responses and rapid clearance of a persis-
tence-prone virus that we described upon genetic attenuation
of TGF-b signaling in T cells not only brings to light a novel mole-
cular mechanism by which persistent viruses curtail immune
responses but also offers promising novel opportunities for the




dnTGFBRII mice (Gorelik and Flavell, 2000) were purchased at The Jackson
laboratory or generously provided by R. Flavell (School of Medicine, Yale
University). C57BL/6 mice or control littermates were used as WT controls.
C57BL/6 CD45.1+ and DbGP33-41 TCR-tg (P14) mice were a generous gift
fromS. Hedrick (University of California, San Diego).Mice were bred andmain-
tained in a closed breeding facility and mouse handling conformed to the
requirements of the National Institutes of Health and the Institutional Animal
Care and Use Guidelines of UCSD. Unless otherwise stated, mice (6–8 weeks
old) were infected intravenously (i.v.) with 23 106 PFU of LCMV ARM or Cl 13.
Rechallenge with LCMV Cl 13 was performed with the same dose and route of
infection as primary infections. Viruses were grown, identified, and quantified
as described (Ahmed et al., 1984; Borrow et al., 1995).
Adoptive Transfer and CD4+ T Cell Depletion
Where indicated, CD8+ T cells were purified from the spleens of naive P14xWT
(CD45.1+CD45.2+) and/or P14xdnTGFBRII (CD45.2+) mice by negative selec-
tion (StemCell Technologies), and equal number (1–10 3 103) Vb8+ cells from
each population were adoptively transferred iv into C57BL/6 CD45.1+ recipient
mice 1–2 days before LCMV Cl 13 infection. Where indicated, P14 cells were
purified after the infection by FACs sort as described before (Zuniga et al.,
2004). For CD4+ T cell depletion, dnTGFBRII mice were intraperitoneally in-
jected with control rat IgG or anti-CD4 (clone GK1.5; 300 mg/mouse) at day
0, 2.5, and 9 p.i. This treatment resulted in >95% reduction in the numbers
of CD4+ T cells at day 5 and 10 p.i. (data not shown). For CD8+ depletion,
mice were injected with anti-CD8+ (clone 53-6.72; 200 mg/mouse) at day 2,
1, 0, and 5 after infection.
Generation of Mixed BM Chimeras
To obtain mixed BM chimeras, WT CD45.1+ C57BL/6 recipient mice were
lethally irradiated with 1000 rads and reconstituted 1 day after with a mixture
of BM cells from CD45.1+ WT mice and CD45.2+ dnTGFBRII mice. Bone
marrow cells were isolated from femurs and tibia of donor mice and 10 million
total cells were i.v. transferred into the irradiated recipient mice. Recipient
mice were treated with antibiotics (Trimethoprim 8 mg/ml and Sulfamethoxa-
zole 40 mg/ml supplied in the drinking water) for 3 weeks to prevent infection
and allow immune reconstitution. Reconstitution was analyzed 6–8 weeks
after bone marrow transfer and the ratio of WT-dnTGFBRII cells was deter-
mined to be %1 for CD8+ T cells. At this point mice were infected with
LCMV Cl 13 as indicated above.
Flow Cytometry
The following antibodies purchased from E-bioscience or BD-bioscience were
used to stain blood or spleen cells: anti-IFN-g APC, anti-TNF-a-FITC, anti-IL-
2-PE, anti-PD-1-PE, anti-Annexin-V-PE, anti-CD45.1-PECy7, anti-CD45.2-
APC-Alexa-750, anti-CD44-PECy7, anti-CD62L-FITC, anti-CD4-Alexa-700,
anti-CD127-PE, anti-CD122-FITC, anti-TGFBR-PE, anti-Ly6C-biotin, Strepta-
vidin-PercP-Cy5.5, and isotype-control-IgG-PE. Anti-CD8-pacific blue was
purchased from Caltag. Anti-p-Smad-2-3 (Ser423-425) was purchased from
Santa Cruz Biotechnology and its control goat IgG from Jackson Immunore-
search. For staining with IAb-GP66-77, D
b-NP396–404, D
b-GP276–286 (providedby NIH Tetramer Core Facility; Atlanta, GA), or Db-GP33–41 (Beckman Coulter;
Fullerton, CA) tetramers, cells were incubated for 1 hr and 15 min at room
temperature. To quantify incorporation of BrdU by tetramer+ CD8+ T cells,
mice were injected with 2 mg of BrdU (Sigma-Aldrich) 16 hr before analysis
and splenocytes stained with BrdU Flow kit (BD Biosciences) according to
the manufacturer’s instructions. Cells were acquired with the Digital LSR II
flow cytometer (Becton Dickinson, San Jose, CA). Flow cytometric data
were analyzed with FlowJo software.
Ex Vivo T Cell Stimulation
Splenocytes were stimulated with 2 mg/ml of the MHC class I-restricted LCMV
NP396–404, GP33–41, or GP276–286 peptides (all >99% pure; Synpep) in the pres-
ence of 50 U/ml recombinant murine IL-2 (R&D Systems) or PMA (10 ng/ml)
and ionomicyn (0.5 mg/ml). Cells were cultured for 5 hr in the presence of bre-
feldin A (1 mg/ml; Sigma) and stained for surface expression of CD8, fixed, per-
meabilized, and stained with Abs to IFN-g, TNF-a, and IL-2. To evaluate cell
degranulation, splenocytes were incubated in the presence of anti-CD107a-
FITC and anti-CD107b-FITC (BD-Biosciences). All cultures without peptide
performed in parallel show no production of cytokines or degranulation.
51Cr Release Assays
LCMV-specific CTL activity was evaluated in splenocytes isolated at day 9 p.i.
by standard 51Cr release assay. MHC-matched MC57 (H-2b) cells either
unloaded or loaded with 1 mg/ml of LCMV NP396–404 or GP33–41 were used
as targets. Cells were mixed at a 50:1 and 100:1 effector/target ratio. Samples
were performed in triplicates and 51Cr release was measured in the superna-
tant after 5 hr as previously described (Borrow et al., 1995).
Immunofluorescence Microscopy
Spleens were removed, frozen in OCT, and cut in 6 mm sections with a Leica
CM3050 S Cryostat. Slides were fixed with 4% PFA for 4 min, washed in
PBS, and then incubated for 1 hr in 5% Normal Donkey Serum followed by
1 hr incubation at RT with a guinea pig anti-LCMV Ab (1:1500). Tissues were
washed and incubated for 1 hr at RT with a FITC-labeled anti-guinea pig Ab
(Jackson Immuno; 1:200). Fluorescence was captured at 103 with an
Olympus DSU Disk Scanning Confocal Microscope, and a montage was
created with SlideBook software.
SDS-PAGE and Immunoblotting
Cells were lysed in a Ripa buffer (Thermo Scientific) containing protease and
phosphatase inhibitors (Calbiochem). Protein homogenates were run on
4%–12% SDS-PAGE gels (Invitrogen) and transferred to a polyvinylidene
difluoride membrane (Millipore) with a semidry transfer cell (Bio-Rad). Blots
were blocked in blocking buffer (phosphate buffer saline [PBS] containing
0.1% tween-20 and 5% nonfat milk) and incubated with primary anti-
pSmad-2, anti-Smad-2-3, anti-TGF-b1, anti-Bim, or anti-phospholipase C g
(PLC-g) mAbs (all from Cell Signaling; 1/1000 in blocking buffer) at 4C over-
night, or at room temperature for 2 hr. HRP-conjugated anti-rabbit IgG (Cell
Signaling; 1/5000 in blocking buffer) was then added for 45 min at room
temperature and ECL (GE Healthcare) was used to visualize the proteins.
Histology and Biochemical Blood Tests
Liver, lung, and stomachwere obtained and fixed in 10% formalin, stainedwith
hematoxylin-eosin, and processed for histopathological analysis at the
Histology and Immunohistochemistry Shared Resource (UCSD). For evalua-
tion of AST, ALT, AP, Glucose, BUN, and creatinine, plasma sampleswere pro-
cessed at the UCSD Chemical and Coagulation Core Laboratory with a Beck-
man CX-7 analyzer.
Real-Time RT-PCR
Total RNA was extracted from splenocytes with RNeasy kits (QIAGEN),
digested with DNase I (RNase-free DNase set; QIAGEN), and reverse tran-
scribed into cDNA. cDNA quantification was performed with SYBR Green
PCR kits (Applied Byosistems) and a Real-Time PCR Detection System
(ABI). The RNA levels of the IL-10 gene (Forward: GGT TGC CAA GCC TTA
TCG GA; Reverse: ACC TGC TCC ACT GCC TTG CT) were normalized to
cellular glyceraldehyde 3-phosphate dehydrogenase (GAPDH) RNA levels.Immunity 31, 145–157, July 17, 2009 ª2009 Elsevier Inc. 155
Immunity
TGF-b Mediates Antiviral CD8 T Cell Deletion In VivoStatistical Analysis
Unpaired Student’s t tests or ANOVA tests were performed with the InStat 3.0
software (GraphPad, CA).
SUPPLEMENTAL DATA
Supplemental Data include ten figures and can be found with this article online
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